Abdominal obesity as a predictor for response to anti-vascular endothelial growth factor therapy in patients with diabetic macular edema
Background and aim Diabetic macular edema (DME) is a major cause of visual disturbance among diabetic patients. Anti-vascular endothelial growth factor (anti-VEGF) therapy has been widely used to treat DME. Obesity is associated with higher levels of circulating VEGF, which may worsen diabetic retin...
Saved in:
Main Authors: | Tamer E. Wasfy, Shaimaa S. Soliman, Nehad Hawash, Elham A. Gad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Journal of the Egyptian Ophthalmological Society |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejos.ejos_25_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Kai Ching Peter Leung, et al.
Published: (2025-02-01) -
Prediction of OCT contours of short-term response to anti-VEGF treatment for diabetic macular edema using generative adversarial networks
by: Xueying Yang, et al.
Published: (2025-04-01) -
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2025-01-01) -
Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
by: Sanjay Kumar Mishra, et al.
Published: (2025-01-01) -
Multifocal electroretinogram evaluation of different optical coherence tomography patterns of diabetic macular edema
by: Abdelrahman W.M. Mohamed, et al.
Published: (2025-01-01)